Table 6.
Model | Activity | Plant part/compd. | Study design | Mechanism | Ref. |
---|---|---|---|---|---|
Bacterial | Antimicrobial activity against Streptococcus mutans | Pericarp extract | Disc inhibition zone method and broth dilution assay; Control=chlorhexidine 0.2% | Growth inhibition; MIC= 50 mg/ml |
(153) |
Bacterial | Antifungal efficacy on Candida albicans | PPE (aqueous decoction) |
Disc diffusion method; The zones of microbial (cultures of Candida albicans) inhibition at 18 and 24 hr | Antifungal activity (P<0.01); Inhibition zone 18.8 mm after 24h and 22 mm after 48 h |
(154) |
Bacterial | Antimicrobial inhibition as a mouthwash | PPE (methanol extract) |
Agar well method (n=3); Incubated at 37 °C for 24 hr; Repeated 3 times; Bacterial strains: Staphylococcus mutants, Staphylococcus aureus, E. coli, Klebsiella pneumonia, Streptococcus gaseous, and Streptococcus faecalis; 25%, 50%, and 75% methanol extract; Control=chlorhexidine gluconate mouthwash | The 50% and 75% extracts exhibited the highest inhibition on S. mutants | (155) |
Bacterial | Antibacterial activity against dental caries and gingivitis S. mutans | PPE (hot and cold aqueous extracts) |
Agar disk diffusion method; S. mutans was isolated from fifty-five patients; 10 μl of aqueous peels extract or 0.2% chlorhexidine (standard); incubated at 37 °C for 24 hr | Inhibition zones: hot (31 mm), cold (27 mm), chlorhexidine (25 mm) | (156) |
Bacterial | Antibacterial activity against Enterococcus faecalis and Candida albicans in root canal dressing | PPE (ethanol extract) |
Inocula of 5.0 × 105 CFU/ml E. faecalis and 1.0 × 103 CFU/ml of C. albicans | ↓Cell viability, biofilm formation; C. Albicans MIC= 62.50 µg/ml; E. faecalis MIC= 15.62 µg/ml |
(157) |
Cellular | Anti-cancer activity against oral cancer | PPE (ethanol extract) |
KB 3-1 oncogenic cell culture; MTT assay; Extract concentrations of 50, 100, 150, 200, 250, 300, and 350 µg | ↓Cell viability | (158) |
Animal | Antifungal activity against oral candidiasis | PPE (methanol extract) |
Male Wistar rats immunosuppressed with cyclosporine (40 mg/kg/d) and hydrocortisone acetate (500 μg/kg/d) except the control group; Induction of oral candidiasis via the oral administration of Candida albicans on the palate and tongue; extract 125, 250, and 500 μg/ml/kg and nystatin 100000 U/ml/kg by gavage daily; 15 days | ↓Growth of C. albicans 100% cure in all the doses after 15 days; Most effective Conc.: 500 μg/ml after 5 days |
(159) |
Clinical | Antimicrobial prophylactic activity on oral bacteria | Fresh fruit juice | 20 patients; A group received 0.2% chlorhexidine mouthwash (10 ml), the other group was given freshly prepared PJ as a mouthwash (75 ml for 2 min); salivary sample pre-rinse and after 15 min | ↓Colony-forming units by pomegranate mouthwash (51.1%) and chlorhexidine mouthwash (71.3%) | (160) |
Clinical | Gingival bleeding reduction | Fruit (ethanol extract) |
Double-blind, interventional, experimental, longitudinal, and prospective RCT, with an inductive approach; N= 55, 18-56 years old; Control=chlorhexidine 0.12% solution mouthwash; Study groups: pomegranate extract mouthwash (twice daily, 1 min long, with 10 ml of the solution); Ainamo and Bay gingival bleeding index (GBI) on 0, 7, and 15 days |
↓Gingival bleeding index (P<0.001) | (161) |
Clinical | Reduction of gingivitis risk | PomElla® (pomegranate extract) | Single-blinded RCT; 19–25 years old, n=32, split evenly among both genders; 4 weeks; saliva sample donation before and after the experiment; randomly assigned pomegranate extract PomElla® dissolved in water or placebo: cornstarch in water (three times a day for 1 min per rinse) | ↓Total protein (P<0.01), aspartate aminotransferase activity (P<0.005), α-Glucosidase activity (P<0.05); ↑Antioxidant enzyme ceruloplasmin activities (P<0.05), radical scavenging capacity (P<0.05) |
(162) |
Clinical | Antibacterial activity against S. mutans | Fruit (mouthwash) |
A single-blinded, parallel-group RCT; n=20; experimental group (I): P. granatum and controlled group (II): chlorhexidine mouthwash; plaque samples evaluated for S. mutans at baseline and 15th day | ↓Mean plaque both groups (group I P=0.043 and group II P=0.047); No significant difference between the two groups at 7th day |
(163) |
Clinical | Treatment of minor recurrent aphthous stomatitis |
P. granatum flowers (pleniflora, sweet Alak, and Saveh black varieties) (ethanol and aqueous extracts) |
Double-blind method; n=210 (69 F and 141 M); experimental group: alcoholic or water extracts (both 10% in 100 ml), negative control: received nothing; using mouthwash for 10 min, four times a day, for 10 days; measuring the size of lesions at days 1,2,4,6,8, and 10, The pain satisfactory degree was recorded | ↓Entire-time of complete treatment; ↑Patients’ satisfactory |
(164) |
Clinical | Antimicrobial activity against S. mutans | Pericarp extract | RCT; 30 children, 6-12 years; Control=chlorhexidine 0.2%; Samples collected before and after mouth rinse | ↓Salivary S. mutans count; No statistically significant difference between PPE and chlorhexidine |
(153) |